Lucem Health

Going from lifestyle modifications to resmetirom and GLP-1 receptor agonists – a look at the evolving landscape of treatment for MASLD and MASH. #LiverDisease #MASH #MASLD https://hubs.ly/Q02S-Z8s0

We're encouraged to see The New York Times bringing attention to Metabolic Associated Steatotic Liver Disease (MASLD) in their recent article. Raising awareness is a vital first step in addressing this growing health challenge. By focusing on supporting healthcare providers with the tools and knowledge they need, we can significantly improve early detection and management of MASLD. Empowered providers lead to better-informed care decisions, ultimately benefiting patients with more effective treatments and improved outcomes. https://lnkd.in/gvxJdggi

🔍 From FIB-4 to AI: Uncover the promising future of liver disease detection and diagnostics. Can AI really improve accuracy? Find out in our latest post! #LiverDisease #EarlyDetection #MASH #MASLD https://hubs.ly/Q02Rgs-70

Catching liver disease early isn't just smart – it pays off financially too. Dig into the details with our latest post about how it leads to reduced downstream care costs and new opportunities for revenue acceleration. #LiverDisease #EarlyDetection #MASH #MASLD https://hubs.ly/Q02QZp5G0

NAFLD's reclassification as MASLD underscores the growing recognition of metabolic factors in liver pathology. This shift is expected to enhance patient screening and management strategies, aligning them more closely with emerging evidence and clinical needs. Learn about this change and what it means in our latest blog post. #LiverDisease #MASLD #MASH #EarlyDetection https://hubs.ly/Q02QtBpY0

A great little amuse bouche on some new ways to think about precision medicine, from Mercy's recent Summit on the subject. Our own Conrad Gudmundson leads off the sound bites... enjoy!

Liver disease rarely headlines health discussions, yet MASLD and MASH are silent, growing threats – affecting about 25% of adults. With obesity, diabetes, and other major factors contributing to their rise, learn why early detection and diagnosis are crucial in our latest blog post. #EarlyDetection #LiverDisease #MASLD #MASH Read the blog post: https://hubs.ly/Q02Q8NwR0

Looking to deepen your knowledge on the intricacies of AI in healthcare? Check out Method’s Tech Talk, AI in Healthcare: Bridging the Gap from Ideas to Impact, tomorrow at 12PM EST! This expert panel discussion, featuring Andy Busam, Alejandro Reti, and our CEO, Sean Cassidy, will be addressing the unique challenges of AI in clinical care. Register here: https://lnkd.in/g5xVGaFW

Save your spot now for Method’s upcoming Tech Talk, AI in Healthcare: Bridging the Gap from Ideas to Impact, on August 29th at 12PM EST! Andy Busam and Alejandro Reti, along side with our CEO, Sean Cassidy, will be providing unique perspectives on the applications and challenges of AI in healthcare. Don’t miss it!